Abstract
Phototherapy has been the mainstay of vitiligo therapy for several decades. A variety
of wavelengths and modalities are available, but narrowband ultraviolet B remains
the safest and most commonly used treatment. Acting on multiple steps in vitiligo
pathogenesis, narrowband ultraviolet B is one of the few therapies that can effectively
induce stabilization and stimulate repigmentation. Achievement of optimal results
involves using a combination of appropriate treatment protocols, careful patient selection,
and patient education to set expectations. Individual patient characteristics, including
disease activity, vitiligo phenotype, lesion location, and skin phototype, should
all be considered, along with combination therapies.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinics in DermatologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Photo(chemo) therapy for vitiligo.Photodermatol Photoimmunol Photomed. 2003; 19: 1-4
- A preliminary clinical report on the treatment of leucoderma with Ammimajus Linn.J Egypt Med Assoc. 1948; 31: 651-665
- Further study on treatment of leucoderma with Ammimafuslinn.J Egypt Med Assoc. 1952; 35: 1-2
- Treatment of vitiligo with psoralen derivatives.AMA Arch Derm. 1955; 71: 14-18
- Clinical and experimental studies with 8-methoxypsoralen in vitiligo.J Invest Dermatol. 1953; 20: 299-314
- Psoralen photobiology and photochemotherapy: 50 years of science and medicine.J Dermatol Sci. 1999; 19: 78-78
- Photochemotherapy of vitiligo. Use of orally administered psoralens and a high-intensity long-wave ultraviolet light system.Arch Dermatol. 1976; 112: 1531-1534
- PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study.Arch Dermatol. 1979; 101: 1-12
- Determination of optimal topical photochemotherapy for vitiligo.J Am Acad Dermatol. 1982; 7: 771-778
- Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligo.Arch Dermatol. 1966; 93: 589-600
- Hindiogˇ lu U, Karaduman A. PUVA treatment of vitiligo: a retrospective study of Turkish patients.Int J Dermatol. 1999; 38: 542-545
- PUVA and PUVB in vitiligo—are they equally effective?.Photodermatol Photoimmunol Photomed. 2001; 17: 159-163
- Narrow band ultraviolet B 311 nm in the treatment of vitiligo: two right-left comparison studies.Photodermatol Photoimmunol Photomed. 2006; 22: 6-11
- A large scale analytical study on efficacy of different photo(chemo) therapeutic modalities in the treatment of psoriasis, vitiligo and mycosis fungoides.Dermatol Ther. 2010; 23: 428-434
- Action spectrum for phototherapy of psoriasis.J Invest Dermatol. 1981; 76: 359-362
- Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.Arch Dermatol. 1997; 133: 1525-1528
- Treatment of vitiligo with NBUVB: a systematic review.J Dermatolog Treat. 2015; 26: 340-346
- BB-UVA vs. NBUVB in the treatment of vitiligo: a randomized controlled clinical study (single blinded).Photodermatol Photoimmunol Photomed. 2013; 29: 239-246
- Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy.J Am Acad Dermatol. 2000; 42: 245-253
- Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy.Int J Dermatol. 2005; 44: 57-60
- Narrow band UVB phototherapy in dermatology.Indian J Dermatol Venereol Leprol. 2004; 70: 205-209
- Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.J Eur Acad Dermatol Venereol. 2006; 20: 175-177
- Comparison of systemic PUVA and NBUVB in the treatment of vitiligo: an open prospective study.J Eur Acad Dermatol Venereol. 2007; 21: 638-642
- Psoralen photochemotherapy (PUVA) is only moderately effective in widespread vitiligo: a 10-year retrospective study.Clin Exp Dermatol. 2002; 27: 104-110
- Consensus workshop on the toxic effects of long-term PUVA therapy.Arch Dermatol. 1998; 134: 595
- Effects of narrow band UVB (311 nm) irradiation on epidermal cells.Int J Mol Sci. 2013; 14: 8456-8466
- First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi.Pigment Cell Melanoma Res. 2010; 23: 84-375
- Systemic low-dose UVB inhibits CD8 T cells and skin inflammation by alternative and novel mechanisms.Am J Pathol. 2011; 178: 2783-2791
- Treatment of Non-Segmental Vitiligo with Narrowband UVB Phototherapy (311 Nm): Clinical Efficacy and Mechanisms of Action.J Clin Exp Dermatol Res. 2014; 5: 240
- Effect of narrow band-ultraviolet B on CD4(+) CD25(high) FoxP3(+) T-lymphocytes in the peripheral blood of vitiligo patients.Photodermatol Photoimmunol Photomed. 2014; 30: 254-261
- T helper 17 and Tregs: a novel proposed mechanism for NBUVB in vitiligo.Exp Dermatol. 2014; 23: 283-286
- Interleukin 17, interleukin 22 and FoxP3 expression in tissue and serum of non-segmental vitiligo: a case controlled study on eighty-four patients.Eur J Dermatol. 2013; 23: 350-355
- Role of oxidative stress in the pathogenesis of vitiligo with special emphasis on the antioxidant action of narrowband ultraviolet B phototherapy.J Int Med Res. 2014; 42: 799-805
- Narrow-band UVB irradiation stimulates the migration and functional development of vitiligo-IgG antibodies-treated pigment cells.J Eur Acad Dermatol Venereol. 2012; 26: 456-464
- A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?.Pigment Cell Res. 2003; 16: 322-332
- Immunohistochemical expression of aberrant Notch-1 signalling in vitiligo: an implication for pathogenesis.Ann Diagn Pathol. 2014; 18: 117-124
- Narrow-band ultraviolet-B stimulates proliferation and migration of cultured melanocytes.Exp Dermatol. 2004; 13: 755-763
- Effects of 1,25-dihydroxyvitamin D3 on human epidermal melanocytes and melanoblasts.J Dermatol Sci. 2014; 76: 72-74
- Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility.PLoS One. 2014; 15e107020
- The effects of NB-UVB on the hair follicle-derived neural crest stem cells differentiating into melanocyte lineage in vitro.J Dermatol Sci. 2012; 66: 20-28
- 312-Nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions.J Exp Med. 1999; 189: 711-718
- Repigmentation of localized vitiligo with the xenon chloride laser.Br J Dermatol. 2001; 44: 1266-1267
- 308-nm excimer laser for the treatment of localized vitiligo.Int J Dermatol. 2003; 42: 658-662
- Monochromatic excimer light 308 nm in the treatment of vitiligo: a pilot study.J Eur Acad Dermatol Venereol. 2003; 17: 531-537
- Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311–313 nm) in the treatment of vitiligo — a multicentre controlled study.J Eur Acad Dermatol Venereol. 2007; 21: 956-963
- Clinical study of repigmentation patterns with either narrow-band ultraviolet B (NBUVB) or 308 nm excimer laser treatment in Korean vitiligo patients.Int J Dermatol. 2010; 49: 317-323
- Short-term effects of 308-nm xenon chloride excimer laser and narrow-band ultraviolet B in the treatment of vitiligo: a comparative study.J Korean Med Sci. 2005; 20: 273-278
- 308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized study.Arch Dermatol. 2010; 163: 188-192
- Narrowband ultraviolet B phototherapy in combination with other therapies for vitiligo: mechanisms and efficacies.J Eur Acad Dermatol Venereol. 2014; 28: 1610-1622
- Why treatments do(n't) work in vitiligo: an autoinflammatory perspective.Autoimmun Rev. 2015; 14: 332-340
- Efficacy and tolerability of combined treatment with NBUVB and topical tacrolimus versus NBUVB alone in patients with vitiligo vulgaris. A randomized intra-individual open comparative trial.Indian J Dermatol Venereol Leprol. 2013; 79: 525-257
- Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck.Arch Dermatol. 2008; 159: 1186-1191
- Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.Arch Dermatol. 2004; 140: 1065-1069
- Narrowband ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of generalized vitiligo.Clin Exp Dermatol. 2010; 35: 919-921
- Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation.Curr Drug Targets. 2008; 9: 345-359
- The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo.JAMA Dermatol. 2013; 149: 68-73
- Oral dexamethasone pulse treatment for vitiligo.J Am Acad Dermatol. 2001; 44: 814-817
- Evaluation of five different regimes for the treatment of vitiligo.Indian J Dermatol Venereol Leprol. 1989; 55: 18-21
- An open labeled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad/narrow band UVB phototherapy in progressive vitiligo.Indian J Dermatol Venereol Leprol. 2008; 74: 357-360
- Oral cyclosporine in the treatment of inflammatory and non inflammatory dermatoses. A clinical and immuno-pathologic analysis.Arch Dermatol. 1990; 126: 339-350
- Unstable vitiligo responding to methotrexate.Indian J Dermatol Venereol Leprol. 1998; 64: 309
- In vivo and in vitro evidence for hydrogen peroxide (H2 O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase.J Investig Dermatol Symp Proc. 1999; 4: 91-96
- Response of vitiligo to narrowband ultraviolet B and oral antioxidants.J Clin Pharmacol. 2009; 49: 852-855
- Comparison of the efficacy of narrow band ultraviolet B and narrow band ultraviolet B plus topical catalase-superoxide dismutase treatment in vitiligo patients.Eur J Dermatol. 2009; 19: 341-344
- Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations.Arch Dermatol. 2012; 166: 208-211
- Effect of one session of ER:YAG laser ablation plus topical 5 fluorouracil on the outcome of short term NBUVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative study.Photodermatol Photoimmunol Photomed. 2008; : 322-329
- Update on skin repigmentation therapies in vitiligo.Pigment Cell Melanoma Res. 2009; 22: 42-65
- A randomized controlled study of the effects of different modalities of narrow-band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo.Dermatol Surg. 2014; 40: 420-426
- Phototherapy with UV-B in vitiligo.Z Hautkr. 1990; 65 ([1029]): 1022-1024
- Ultraviolet A in vitiligo.Photodermatol Photoimmunol Photomed. 2006; : 214-216
- A new apparatus with high radiation energy between 320–460 nm: physical description and dermatological applications.J Invest Dermatol. 1981; 76: 42-47
- Association of targeted intense pulse light system UVA1-UVB and fluticasone in the treatment of vitiligo: prospective study of 10 patients.Dermatol Online J. 2010; 16: 15
- The incidence of leukotrichia in segmental vitiligo: implication of poor response to medical treatment.Int J Dermatol. 2011; 50: 925-927
- Surgical management of vitiligo and other leukodermas: evidence-based practice guidelines.in: Gupta S. Olsson M.J. Kanwar A. Ortonne J.P. Surgical management of vitiligo. Blackwell Publishing, Malden, MA2007: 69-79
- Vitiligo Potential Repigmentation Index: a simple clinical score that might predict the ability of vitiligo lesions to repigment under therapy.Arch Dermatol. 2013; 168: 1143-1146
- The hair follicle melanocytes in vitiligo in relation to disease duration.J Eur Acad Dermatol Venereol. 2009; 23: 934-939
- The effectiveness of early treatment in segmental vitiligo: retrospective study according to disease duration.Photodermatol Photoimmunol Photomed. 2013; 29: 103-105
- Poor response of phototherapy in segmental vitiligo with leukotrichia: role of digital microscopy.Int J Dermatol. 2012; 51: 873-875
- Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy.J Am Acad Dermatol. 2007; 56: 274-278
- Parametric modeling of narrowband UV-B phototherapy for vitiligo, using a novel quantitative tool: the vitiligo area scoring index.Arch Dermatol. 2004; 140: 677-683
- Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians.J Am Acad Dermatol. 2003; 49: 473-476
- Minimal erythema dose to targeted phototherapy in vitiligo patients in Indian skin.Indian J Dermatol Venereol Leprol. 2013; 79: 268
- Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature.Arch Dermatol. 1998; 134: 1532-1540
- A proposal for the treatment guideline in segmental vitiligo.Int J Dermatol. 2012; 51: 1274-1275
- Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo.Arch Dermatol. 2011; 165: 285-291
- Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study.Photodermatol Photoimmunol Photomed. 2010; 26: 230-234
- Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan.J Eur Acad Dermatol Venereol. 2015; 29: 1362-1369
- Recent onset vitiligo on acral areas treated with phototherapy: need of early treatment.Photodermatol Photoimmunol Photomed. 2010; 26: 266-268
- Narrow-band UVB treatment of vitiligo in Chinese.J Dermatol. 2005; 32: 793-800
- Phototherapy in vitiligo: assessing the compliance, response and patient's perception about disease and treatment.Indian J Dermatol. 2013; 58: 325
- Epidermal photoprotection: comparative study of narrowband ultraviolet B minimal erythema doses with and without stratum corneum stripping in normal and vitiligo skin.Clin Exp Dermatol. 2011; 36: 393-398
- Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study.Int J Dermatol. 2012; 51: 1107-1115
- Evaluation of the effects of NBUVB in both segmental and non-segmental vitiligo affecting different body sites.Photodermatol Photoimmunol Photomed. 2006; 22: 157-163
- Photo(chemo)therapy for vitiligo.Photodermatol Photoimmunol Photomed. 2011; 27: 261-277
- Spectrophotometric measurement of minimal erythema dose sites after narrowband ultraviolet B phototesting: clinical implication of spetrophotometric values in phototherapy.Ann Dermatol. 2014; 26: 17-25
- Photoadaptation: a path toward rational phototherapy protocols.J Invest Dermatol. 2006; 126: 2156-2158
- Vitiligo European Task Force (VETF); European Academy of Dermatology and Venereology (EADV); Union Européanne des Médecins Spécialistes (UEMS). Guidelines for the management of vitiligo: the European Dermatology Forum consensus.Arch Dermatol. 2013; : 1685-1619
- Prediction of the occurrence of melanoma and non-melanoma skin cancer in patients with vitiligo.Acta Derm Venereol. 2016 Jan; 96: 106-107
Article info
Identification
Copyright
© 2016 Elsevier Inc. All rights reserved.
